Abdel-Rahman SZ, Ammenheuser MM, Ward JB Jr.: Human sensitivity to 1,3-butadiene: role of microsomal epoxide hydrolase polymorphisms. Carcinogenesis. 2001, 22 (3): 415-23.
Agundez JA, Martinez C, Ladero JM, Ledesma MC, Ramos JM, Martin R, Rodriguez A, Jara C, Benitez J.: Debrisoquin oxidation genotype and susceptibility to lung cancer. Clin
Pharmacol Ther. 1994, 55 (1): 10-4.
Agundez JA, Ledesma MC, Ladero JM, Benitez J.: Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population. Clin Pharmacol Ther.
1995, 57 (3): 265-9.
Ahmad H, Wilson DE, Fritz RR, Singh SV, Medh RD, Nagle GT, Awasthi YC, Kurosky A.:
Primary and secondary structural analyses of glutathione S-transferase pi from human placenta. Arch Biochem Biophys. 1990,278 (2): 398-408.
Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, Ingelman-Sundberg M.:
Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J Pharmacol Exp Ther.
1996, 278 (1): 441-6.
Alexandrie AK, Sundberg MI, Seidegard J, Tornling G, Rannug A.: Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis. 1994, 15 (9):
1785-90.
Alexandrie AK, Warholm M, Carstensen U, Axmon A, Hagmar L, Levin JO, Ostman C, Rannug A.: CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure. Carcinogenesis. 2000, 21 (4): 669-76.
Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J.: Molecular cloning,
characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997,272 (15): 10004-12.
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ.: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25 (17): 3389-402.
Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Laughlin R, Nemoto T, Michalek AM, Harrington A.. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res. 1995, 55 (16): 3483-5.
Anderson WB, Board PG, Gargano B, Anders MW.: Inactivation of glutathione transferase zeta by dichloroacetic acid and other fluorine-lacking alpha-haloalkanoic acids. Chem Res Toxicol. 1999, 12 (12): 1144-9.
Anttila S, Hirvonen A, Vainio H, Husgafvel-Pursiainen K, Hayes JD, Ketterer B.:
Immunohistochemical localization of glutathione S-transferases in human lung. Cancer Res.
1993, 53 (23): 5643-8.
Anttila S, Luostarinen L, Hirvonen A, Elovaara E, Karjalainen A, Nurminen T, Hayes JD, Vainio H, Ketterer B.: Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: association with GSTM1 polymorphism, smoking, and asbestos exposure. Cancer Res. 1995, 55 (15): 3305-9.
Anttila S, Lei XD, Elovaara E, Karjalainen A, Sun W, Vainio H, Hankinson O.: An uncommon phenotype of poor inducibility of CYP1A1 in human lung is not ascribable to polymorphisms in the AHR, ARNT, or CYP1A1 genes. Pharmacogenetics. 2000, 10 (8): 741-51.
Anttila S, Tuominen P, Hirvonen A, Nurminen M, Karjalainen A, Hankinson O, Elovaara E. : CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Pharmacogenetics. 2001, 11 (6): 501-9.
Arand M, Muhlbauer R, Hengstler J, Jager E, Fuchs J, Winkler L, Oesch F.: A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem. 1996, 236 (1): 184-6.
Armstrong RN.: Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol. 1997, 10 (1): 2-18.
ATS Statement: Standards for the diagnosis and care of patients with chronic abstructive pulmonary disease. Am J Cri Care Med 1995, 152: 77-120
Ayesh R, Idle JR, Ritchie JC, Crothers MJ, Hetzel MR.: Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature. 1984, 312 (5990): 169-70.
Bakker J, Lin X, Nelson WG.: Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells. J Biol Chem. 2002, 277 (25): 22573-80.
Bale, A. E., Nebert, D. W., and McBnde, 0. W.: Subchromosomallocalization of the dioxin-inducible P450 locus (CYPl) and description of two RFLPs detected with a 3' P450 cDNA probe. Cytogen. Cell Genel. , 1987, (46), 574.
Baranov VS, Ivashchenko TE, Shved NIu, Iarmolinskata MI, Sel'kov SA, Gorbushin SM, Savitskii GA, Malet P, Kanis M, Bruhat M, Baranova E.: Genetic factors of predisposition to endometriosis and response to its treatment. Genetika. 1999, 35 (2): 243-8.
Baranova H, Perriot J, Albuisson E, Ivaschenko T, Baranov VS, Hemery B, Mouraire p, Riol N, Malet P.: Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. Hum Genet, (1997), 99 (6): 822-6.
Barnes PJ.: Molecular mechanisms of glucocorticoid action in asthma. Pulm Pharmacol Ther. 1997;10 (1): 3-19.
Bartsch H, Hietanen E.: The role of individual susceptibility in cancer burden related to environmental exposure. Environ Health Perspect. 1996, 104 (3):569-77.
Bartsch H, Rojas M, Nair U, Nair J, Alexandrov K. : Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers. Cancer Detect Prev.
1999, 23 (6): 445-53.
Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K.: Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev. 2000, 9 (1): 3-28.
Bascom R.: Differential susceptibility to tobacco smoke: possible mechanisms.
Pharmacogenetics. 1991, 1 (2): 102-6.
Beatty K, Bieth J, Travis J.: Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem. 1980, 255 (9): 3931-4.
Bell DA, Thompson CL, Taylor J, Miller CR, Perera F, Hsieh LL, Lucier GW.: Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction:
application to glutathione transferase mu. Environ Health Perspect. 1992, 98:113-7.
Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW.: Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene
glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst. 1993, 85 (14): 1159-64.
Bergen AW, Caporaso N.: Cigarette smoking. J Natl Cancer Inst. 1999, 91 (16): 1365-75.
Bernardini S, Hirvonen A, Pelin K, Norppa H.: Induction of sister chromatid exchange by 1,2-epoxy-3-butene in cultured human lymphocytes: influence of GSTT1 genotype.
Carcinogenesis. 1998, 19 (2): 377-80.
Bernardini S, Pelin K, Peltonen K, Jarventaus H, Hirvonen A, Neagu C, Sorsa M, Norppa H.:
Induction of sister chromatid exchange by 3,4-expoxybutane-1,2-diol in cultured human lymphocytes of different GSTT1 and GSTM1 genotypes. Mutat Res. 1996, 361 (2-3): 121-7.
Bertilsson L.: Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet. 1995, 29 (3): 192-209.
Blackburn AC, Woollatt E, Sutherland GR, Board PG.: Characterization and chromosome location of the gene GSTZ1 encoding the human Zeta class glutathione transferase and maleylacetoacetate isomerase. Cytogenet Cell Genet. 1998;83 (1-2): 109-14.
Blackburn AC, Tzeng HF, Anders MW, Board PG.: Discovery of a functional polymorphism in human glutathione transferase zeta by expressed sequence tag database analysis.
Pharmacogenetics. 2000, 10 (1): 49-57.
Blackburn AC, Coggan M, Tzeng HF, Lantum H, Polekhina G, Parker MW, Anders MW, Board PG.: GSTZ1d: a new allele of glutathione transferase zeta and maleylacetoacetate isomerase. Pharmacogenetics. 2001, 11 (8): 671-8.
Blue ML, Janoff A.: Possible mechanisms of emphysema in cigarette smokers. Release of elastase from human polymorphonuclear leukocytes by cigarette smoke condensate in vitro.
Am Rev Respir Dis. 1978, 117 (2): 317-25.
Board PG.: Transport of glutathione S-conjugate from human erythrocytes. FEBS Lett. 1981, 23;124 (2): 163-5.
Board PG.: Biochemical genetics of glutathione-S-transferase in man. Am J Hum Genet.
1981, 33 (1): 36-43.
Board PG, Pierce K.: Expression of human glutathione S-transferase 2 in Escherichia coli.
Immunological comparison with the basic glutathione S-transferases isoenzymes from human liver. Biochem J. 1987, 248 (3): 937-41.
Board PG, Suzuki T, Shaw DC.: Human muscle glutathione S-transferase (GST-4) shows close homology to human liver GST-1. Biochim Biophys Acta. 1988;953 (3): 214-7.
Board PG, Webb GC, Coggan M.: Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann Hum Genet. 1989, 53 :205-13.
Board P, Coggan M, Johnston P, Ross V, Suzuki T, Webb G.: Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther. 1990;48 (3):
357-69.
Board PG, Coggan M, Woodcock DM.: The human Pi class glutathione transferase
sequence at 12q13-q14 is a reverse-transcribed pseudogene. Genomics. 1992, 14 (2): 470-3.
Board PG, Baker RT, Chelvanayagam G, Jermiin LS.: Zeta, a novel class of glutathione transferases in a range of species from plants to humans. Biochem J. 1997, 328 :929-35.
Board PG.: Identification of cDNAs encoding two human alpha class glutathione transferases (GSTA3 and GSTA4) and the heterologous expression of GSTA4-4. Biochem J. 1998, 330:
827-31.
Board PG, Coggan M, Chelvanayagam G, Easteal S, Jermiin LS, Schulte GK, Danley DE, Hoth LR, Griffor MC, Kamath AV, Rosner MH, Chrunyk BA, Perregaux DE, Gabel CA, Geoghegan KF, Pandit J.: Identification, characterization, and crystal structure of the Omega class glutathione transferases. J Biol Chem. 2000, 275 (32): 24798-806.
Board PG, Chelvanayagam G, Jermiin LS, Tetlow N, Tzeng HF, Anders MW, Blackburn AC.:
Identification of novel glutathione transferases and polymorphic variants by expressed sequence tag database analysis. Drug Metab Dispos. 2001, 29: 544-7.
Borde-Chiche P, Diederich M, Morceau F, Wellman M, Dicato M.: Phorbol ester
responsiveness of the glutathione S-transferase P1 gene promoter involves an inducible c-jun binding in human K562 leukemia cells. Leuk Res. 2001a, 25 (3): 241-7.
Borde-Chiche P, Diedericha M, Morceau F, Puga A, Wellman M, Dicato M.: Regulation of transcription of the glutathione S-transferase P1 gene by methylation of the minimal promoter in human leukemia cells. Biochem Pharmacol. 2001b, 61 (5): 605-12.
Bottiger Y, Dostert P, Benedetti MS, Bani M, Fiorentini F, Casati M, Poggesti I, Alm C, Alvan G, Bertilsson L.: Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humans. Br J Clin Pharmacol. 1996, 42 (6): 707-11.
Bouchardy C, Benhamou S, Dayer P.: The effect of tobacco on lung cancer risk depends on CYP2D6 activity. Cancer Res. 1996, 56 (2): 251-3.
Bouchardy C, Benhamou S, Dayer P.: Re: London,S.J. et al. (1997) Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County. Carcinogenesis, 18, 1203-1214. Carcinogenesis. 1998, 19 (3): 533-5.
Boustead C, Taber H, Idle JR, Cholerton S.: CYP2D6 genotype and smoking behaviour in cigarette smokers.Pharmacogenetics. 1997, 7 (5): 411-4.
Brantigan OC, Kress MB, and Goco RB: Pulmonary emboli. A factor in the etiology and pathogenesis of pulmonary emphysema. Chest 1966, 49: 491-501.
Breen JJ, Hickok NJ, Gurr JA.: The rat TSHbeta gene contains distinct response elements for regulation by retinoids and thyroid hormone. Mol Cell Endocrinol. 1997, 131 (2): 137-46.
Brockmoller J, Gross D, Kerb R, Drakoulis N, Roots I.: Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class mu gene detected by polymerase chain reaction. Biochem Pharmacol.
1992, 43 (3): 647-50.
Brockmoller J, Kerb R, Drakoulis N, Nitz M, Roots I.: Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controls. Cancer Res. 1993, 53 (5): 1004-11.
Brockmöller J, Kerb R, Drakoulis N, Staffeldt B, Roots I.: Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study.
Cancer Res. 1994, 54 (15): 4103-11.
Brockmöller J, Cascorbi I, Kerb R, Roots I.: Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res. 1996, 56 (17): 3915-25.
Brockmöller J, Cascorbi I, Kerb R, Sachse C, Roots I.: Polymorphisms in xenobiotic conjugation and disease predisposition. Toxicol Lett. 1998, 102-103:173-83.
Broly F, Gaedigk A, Heim M, Eichelbaum M, Morike K, Meyer UA.: Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population. DNA Cell Biol. 1991, 10 (8): 545-58.
Butkiewicz D, Grzybowska E, Hemminki K, Ovrebo S, Haugen A, Motykiewicz G, Chorazy M.: Modulation of DNA adduct levels in human mononuclear white blood cells and
granulocytes by CYP1A1 CYP2D6 and GSTM1 genetic polymorphisms. Mutat Res. 1998, 415 (1-2): 97-108.
Campbell EJ, Wald MS.: Hypoxic injury to human alveolar macrophages accelerates release of previously bound neutrophil elastase. Implications for lung connective tissue injury
including pulmonary emphysema. Am Rev Respir Dis. 1983, 127 (5): 631-5.
Campbell JA, Corrigall AV, Guy A, Kirsch RE.: Immunohistologic localization of alpha, mu, and pi class glutathione S-transferases in human tissues. Cancer. 1991, 67 (6): 1608-13.
Cantlay AM, Smith CA, Wallace WA, Yap PL, Lamb D, Harrison DJ.: Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax.
1994, 49 (10): 1010-4.
Carrozzi L, Pistelli F, Fornai E, Desideri M, Viegi G, Giuntini C.: Smoking cessation clinic: an Italian experience. Monaldi Arch Chest Dis. 2000, 55 (6): 502-5.
Carver LA, Bradfield CA.: Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J Biol Chem. 1997, 272 (17): 11452-6.
Casanova M, Bell DA, Heck HD.: Dichloromethane metabolism to formaldehyde and reaction of formaldehyde with nucleic acids in hepatocytes of rodents and humans with and without glutathione S-transferase T1 and M1 genes. Fundam Appl Toxicol. 1997, 37 (2): 168-80.
Cascorbi I, Drakoulis N, Brockmoller J, Maurer A, Sperling K, Roots I.: Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian
individuals: correlation with phenotypic activity. Am J Hum Genet. 1995, 57 (3): 581-92.
Cascorbi I, Brockmoller J, Roots I.: A C4887A polymorphism in exon 7 of human CYP1A1:
population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res. 1996a, 56 (21): 4965-9.
Catteau A, Douriez E, Beaune P, Poisson N, Bonaiti-Pellie C, Laurent P.: Genetic polymorphism of induction of CYP1A1 (EROD) activity. Pharmacogenetics. 1995, 5 (2): 110-9.
Chen S, Chou WH, Blouin RA, Mao Z, Humphries LL, Meek QC, Neill JR, Martin WL, Hays LR, Wedlund PJ.: The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry. Clin Pharmacol Ther. 1996, 60 (5):
522-34.
Chen W, Kubota S, Nishimura Y, Nozaki S, Yamashita S, Nakagawa T, Kameda-Takemura K, Menju M, Matsuzawa Y, Bjorkhem I, Eggertsen G, Seyama Y.: Genetic analysis of a Japanese cerebrotendinous xanthomatosis family: identification of a novel mutation in the adrenodoxin binding region of the CYP 27 gene. Biochim Biophys Acta. 1996, 1317 (2): 119-26.
Chenevix-Trench G, Young J, Coggan M, Board P.: Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis. 1995, 16
(7): 1655-7.
Christensen PM, Gotzsche PC, Brosen K.: The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis. Eur J Clin Pharmacol. 1997;51 (5): 389-93.
Church DF, Pryor WA.: Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect. 1985, 64:111-26.
Coggan M, Whitbread L, Whittington A, Board P.: Structure and organization of the human theta-class glutathione S-transferase and D-dopachrome tautomerase gene complex.
Biochem J. 1998, 334: 617-23.
Cohn JR.: Interstitial lung disease and cancer chemotherapy. Ann Intern Med. 1979, 90 (5):
856.
Cole EG, Gaston K.: A functional YY1 binding site is necessary and sufficient to activate Surf-1 promoter activity in response to serum growth factors. Nucleic Acids Res. 1997, 25 (18): 3705-11.
Coles B, Ketterer B.: The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol. 1990, 25 (1): 47-70.
Coles BF, Morel F, Rauch C, Huber WW, Yang M, Teitel CH, Green B, Lang NP, Kadlubar FF.: Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics. 2001, 11 (8): 663-9.
Coles BF, Chen G, Kadlubar FF, Radominska-Pandya A.: Interindividual variation and organ-specific patterns of glutathione S-transferase alpha, mu, and pi expression in gastrointestinal tract mucosa of normal individuals. Arch Biochem Biophys. 2002, 403 (2): 270-6.
Comstock KE, Johnson KJ, Rifenbery D, Henner WD.: Isolation and analysis of the gene and cDNA for a human Mu class glutathione S-transferase, GSTM4. J Biol Chem. 1993, 268 (23):
16958-65.
Conforti-Froes N, el-Zein R, Abdel-Rahman SZ, Zwischenberger JB, Au WW.: Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers. Mutat Res.
1997, 379 (1): 53-9.
Cooley JC and Gillespie JB: Mediastinal emphysema: pathogenesis and management.
Report of a case. Chest 1966, 49: 104-108.
Cornett R, James MO, Henderson GN, Cheung J, Shroads AL, Stacpoole PW.: Inhibition of glutathione S-transferase zeta and tyrosine metabolism by dichloroacetate: a potential unifying mechanism for its altered biotransformation and toxicity. Biochem Biophys Res Commun. 1999, 262 (3): 752-6.
Corrigan CJ, Kay AB.: The roles of inflammatory cells in the pathogenesis of asthma and of chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991, 143: 1165-8
Corrigan CJ, Kay AB.: The roles of inflammatory cells in the pathogenesis of asthma and of chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991, 143 (5): 1165-8
Cortessis V, Siegmund K, Chen Q, Zhou N, Diep A, Frankl H, Lee E, Zhu QS, Haile R, Levy D.: A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas. Cancer Res. 2001, 61 (6):
2381-5.
Cosma G, Crofts F, Currie D, Wirgin I, Toniolo P, Garte SJ.: Racial differences in restriction fragment length polymorphisms and messenger RNA inducibility of the human CYP1A1 gene. Cancer Epidemiol Biomarkers Prev. 1993;2 (1): 53-7.
Cosma, G., Crofts, F., Taloli, E., Toniolo, P., and Garte, S.: Relationship between genotype and function of the human CYP1A1 gene. I. ToxicoL Envirollt; Health 40, 309, 1993
Cox DW and Levison H.: Emphysema od early onset associated with a complete deficiency of alpha-1-antitrypsin (null homozygotes). Am Rev Respir Dis 137 (2): 371-5.(1988)
Cox DW, Markovic VD, Teshima IE.: Genes for immunoglobulin heavy chains and for alpha 1-antitrypsin are localized to specific regions of chromosome 14q. Nature. 1982;297 (5865):
428-30.
Cox DW., Scriver CR, Beaudet AL, Sly WS, Valle D, eds.The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York: McGraw-Hill, 1995;Alpha 1-Antitrypsin deficiency. p.
2407-37.
Crawford EL, Khuder SA, Durham SJ, Frampton M, Utell M, Thilly WG, Weaver DA, Ferencak WJ, Jennings CA, Hammersley JR, Olson DA, Willey JC.: Normal bronchial epithelial cell expression of glutathione transferase P1, glutathione transferase M3, and glutathione peroxidase is low in subjects with bronchogenic carcinoma. Cancer Res. 2000;
60 (6): 1609-18.
Crofts F, Cosma GN, Currie D, Taioli E, Toniolo P, Garte SJ.: A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis. 1993, 14 (9): 1729-31.
Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, Toniolo P, Garte SJ.: Functional significance of different human CYP1A1 genotypes. Carcinogenesis. 1994, 15 (12): 2961-3.
Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999, 160 (5): 1635-9.
Dahl ML, Johansson I, Bertilsson L, Ingelman-Sundberg M, Sjoqvist F.: Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis. J Pharmacol Exp Ther. 1995, 274 (1): 516-20.
Daly AK, Brockmoller J, Broly F, Eichelbaum M, Evans WE, Gonzalez FJ, Huang JD, Idle JR, Ingelman-Sundberg M, Ishizaki T, Jacqz-Aigrain E, Meyer UA, Nebert DW, Steen VM, Wolf CR, Zanger UM.: Nomenclature for human CYP2D6 alleles. Pharmacogenetics. 1996 (a), 6 (3): 193-201.
Daly AK, Fairbrother KS, Andreassen OA, London SJ, Idle JR, Steen VM.: Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype. Pharmacogenetics. 1996 (b), 6 (4): 319-28.
Daly AK, Fairbrother KS, Smart J.: Recent advances in understanding the molecular basis of polymorphisms in genes encoding cytochrome P450 enzymes. Toxicol Lett. 1998 Dec 28;102-103:143-7.
Daly AK, Steen VM, Fairbrother KS, Idle JR.: CYP2D6 multiallelism. Methods Enzymol. 1996 (c);272:199-210.
Davies MH, Elias E, Acharya S, Cotton W, Faulder GC, Fryer AA, Strange RC.: GSTM1 null polymorphism at the glutathione S-transferase M1 locus: phenotype and genotype studies in patients with primary biliary cirrhosis. Gut. 1993, 34 (4): 549-53.
de Groat, M. J. and Vermeu1en, N. P. E., Modeling the active sites of cytochrome P450s and glutathione-S-transferases, two of the most important biotransfor- mation enzymes. Drug.
Metab. Rev. 29, 747, 1997.
Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin D, Pantin C, Wild N, Leopard P, Bell DA, Jones P, Duncan H, Brannigan K, Alldersea J, Fryer AA, Strange RC.: Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis. 1996, 17 (4): 881-4.
DeMarini DM, Shelton ML, Warren SH, Ross TM, Shim JY, Richard AM, Pegram RA.:
Glutathione S-transferase-mediated induction of GC-->AT transitions by halomethanes in Salmonella. Environ Mol Mutagen. 1997;30 (4): 440-7.
Denison MS, Fisher JM, Whitlock JP Jr.: Protein-DNA interactions at recognition sites for the dioxin-Ah receptor complex. J Biol Chem. 1989 Oct 5;264 (28): 16478-82.
DHHS: Unified agenda of regulation--DHHS. Publication of unified agenda of regulations.
Fed Regist. 1985 Apr 29;50 (82 Pt 1): 17210-83.
Doelman CJ, Leurs R, Oosterom WC, Bast A.: Mineral dust exposure and free radical-mediated lung damage. Exp Lung Res 16 (1): 41-55.(1990)
Doll JA, Zhu X, Furman J, Kaleem Z, Torres C, Humphrey PA, Donis-Keller H.: Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis). Am J Pathol. 1999, 155 (3): 967-71.
Doll R, Peto R, Hall E, Wheatley K, Gray R.: Mortality in relation to consumption of alcohol:
13 years' observations on male British doctors. BMJ. 1994 Oct 8;309 (6959): 911-8.
Doll R.:Risk from tobacco and potentials for health gain. Int J Tuberc Lung Dis. 1999, 3 (2):
90-9.
Dolzan V, Rudolf Z, Breskvar K.: Human CYP2D6 gene polymorphism in Slovene cancer patients and healthy controls. Carcinogenesis. 1995, 16 (11): 2675-8.
Dong MS, Yamazaki H, Guo Z, Guengerich FP.: Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase. Arch Biochem Biophys. 1996; 327 (1): 11-9.
Duncan H, Swan C, Green J, Jones P, Brannigan K, Alldersea J, Fryer AA, Strange RC.:
Susceptibility to ulcerative colitis and Crohn's disease: interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes. Clin Chim Acta. 1995; 240 (1): 53-61.
Easton D, Peto J.: The contribution of inherited predisposition to cancer incidence. Cancer Surv. 1990;9 (3): 395-416.
Elexpuru-Camiruaga J, Buxton N, Kandula V, Dias PS, Campbell D, McIntosh J, Broome J, Jones P, Inskip A, Alldersea J.: Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res. 1995; 55 (19): 4237-9.
El-Zein R, Zwischenberger JB, Wood TG, Abdel-Rahman SZ, Brekelbaum C, Au WW.:
Combined genetic polymorphism and risk for development of lung cancer. Mutat Res. 1997;
381 (2): 189-200.
Eriksson S.: Therapeutic possibilities in alpha-1-antitrypsin deficiency Lakartidningen. 1981;
78 (41): 3593-6.
Erkinjuntti-Pekkanen R, Reiman M, Kokkarinen JI, Tukiainen HO, Terho EO.: IgG antibodies, chronic bronchitis, and pulmonary function values in farmer's lung patients and matched controls. Allergy. 1999, 54 (11): 1181-7.
Erkinjuntti-Pekkanen R, Rytkonen H, Kokkarinen JI, Tukiainen HO, Partanen K, Terho EO.:
Long-term risk of emphysema in patients with farmer's lung and matched control farmers. Am J Respir Crit Care Med, 1998, 158 (2): 662-5.
Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG.: Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.
Cancer Res. 1998; 58 (20): 4515-8.
Esteller M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J.: Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci. Br J Cancer. 1997;75 (9): 1385-8.
Esther RJ, Lamps L, Schwartz HS.: Marjolin ulcers: secondary carcinomas in chronic wounds. J South Orthop Assoc. 1999; 8 (3): 181-7.
Evert B, Griese EU, Eichelbaum M.: Cloning and sequencing of a new non-functional CYP2D6 allele: deletion of T1795 in exon 3 generates a premature stop codon.
Pharmacogenetics. 1994, 4 (5): 271-4.
Fabbri L, Beghe B, Caramori G, Papi A, Saetta M.: Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease. Thorax. 1998, 53 (9):
803-8.
Fagerhol MK, Hauge HE.: The Pi phenotype MP. Discovery of a ninth allele belonging to the system of inherited variants of serum alpha 1 antitrypsin.
Fletcher CM, Pride NB.: Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium. Thorax. 1984, 39 (2): 81-5.
Ford JG, Li Y, O'Sullivan MM, Demopoulos R, Garte S, Taioli E, Brandt-Rauf PW.:
Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans.
Carcinogenesis. 2000, 21 (11): 1971-5.
Fost U, Tornqvist M, Leutbecher M, Granath F, Hallier E, Ehrenberg L.: Effects of variation in detoxification rate on dose monitoring through adducts. Hum Exp Toxicol. 1995, 14 (2): 201-3.
Fryer AA, Bianco A, Hepple M, Jones PW, Strange RC, Spiteri MA.: Polymorphism at the glutathione S-transferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma. Am J Respir Crit Care Med. 2000, 161 (5): 1437-42.
Fryer AA, Zhao L, Alldersea J, Boggild MD, Perrett CW, Clayton RN, Jones PW, Strange RC.: The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas. Carcinogenesis. 1993, 14 (4):
563-6.
Fryer AA, Zhao L, Alldersea J, Pearson WR, Strange RC.: Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A,B and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus. Biochem J. 1993 Oct 1;295 ( Pt 1): 313-5.
Gadek JE, Pacht ER.: Pathogenesis of hereditary emphysema and replacement therapy for alpha 1-antitrypsin deficiency. Insight into the more common forms of emphysema. Chest.
1996, 110 (6): 248S-250.
Gaedigk A, Blum M, Gaedigk R, Eichelbaum M, Meyer UA.: Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor
metabolizers of the debrisoquine/sparteine polymorphism. Am J Hum Genet. 1991, 48 (5):
943-50.
Garcia-Closas M, Kelsey KT, Wiencke JK, Xu X, Wain JC, Christiani DC.: A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States). Cancer Causes Control. 1997, 8 (4):
544-53.
Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmoller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell'Omo M, Dolzan V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, van Lieshout EM, London S, Manni JJ, Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Parl FF, Pastorelli R, Persson I, Peters WH, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M, Ryberg D, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnet D, Strange RC, Stucker I, Sugimura H, To-Figueras J, Vineis P, Yu MC, Taioli E. : Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001, 10 (12): 1239-48.